The Phage Lytic Proteins from the Staphylococcus aureus Bacteriophage vB_SauS-phiIPLA88 Display Multiple Active Catalytic Domains and Do Not Trigger Staphylococcal Resistance

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Rodríguez Rubio, Lorena ^a   Martínez, Beatriz ^a   Rodríguez, Ana ^a   Donovan, David M ^b   Götz, Friedrich ^c   García, Pilar ^a  

^a DEPARTMENT OF MICROBIOLOGY AND BIOCHEMISTRY OF DAIRY PRODUCTS   (Spain)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; ENDOLYSINE H5; LYSOSTAPHIN; PEPTIDOGLYCAN; PHAGE LYTIC PROTEIN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG SCREENING; DRUG STRUCTURE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHAGE DISPLAY; PROTEIN CLEAVAGE; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INTERACTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS PHAGE;

AMINO ACID SEQUENCE; CATALYTIC DOMAIN; DRUG RESISTANCE, BACTERIAL; ENDOPEPTIDASES; LYSOSTAPHIN; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; N-ACETYLMURAMOYL-L-ALANINE AMIDASE; PEPTIDOGLYCAN; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS PHAGES;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS AUREUS;

EID: 84878406801     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064671     Document Type: Article

References (29)

1. Lowy FD, (1998) Staphylococcus aureus infections. N Engl J Med 339: 520-532.
2. Appelbaum PC (2006) MRSA-the tip of the iceberg. Clin Microbiol Infect Suppl 2: 3-10. Review.
3. Appelbaum PC (2006) The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus. Clin Microbiol Infect Suppl 1: 16-23. Review.
4. Nelson DC, Schmelcher M, Rodriguez-Rubio L, Klumpp J, Pritchard DG, et al. (2012) Endolysins as antimicrobials. Adv Virus Res 83: 299-365.
5. Rodríguez-Rubio L, Martínez B, Donovan DM, Rodríguez A, García P (2012) Bacteriophage virion-associated peptidoglycan hydrolases: potential new enzybiotics. Crit Rev Microbiol doi:10.3109/1040841X.2012.723675.
6. Fenton M, Ross P, McAuliffe O, O'Mahony J, Coffey A, (2010) Recombinant bacteriophage lysins as antibacterials. Bioeng Bugs 1: 9-16.
7. Shen Y, Mitchell MS, Donovan DM, Nelson DC (2012) Phage-based Enzybiotics. In: Hyman P, Abedon ST, editors. Bacteriophages in Health and Disease. Wallingford, UK: CAB International. 217-239.
8. Schmelcher M, Donovan DM, Loessner MJ, (2012) Bacteriophage endolysins as novel antimicrobials. Future Microbiol 7(10): 1-25.
9. Rashel M, Uchiyama J, Ujihara T, Uehara Y, Kuramoto S, et al. (2007) Efficient elimination of multidrug-resistant Staphylococcus aureus by cloned lysin derived from bacteriophage phi MR11. J Infect Dis 196: 1237-1247.
10. Gu J, Xu W, Lei L, Huang J, Feng X, et al. (2011) LysGH15, a novel bacteriophage lysin, protects a murine bacteremia model efficiently against lethal methicillin-resistant Staphylococcus aureus infection. J Clin Microbiol 49: 111-117.
11. Navarre WW, Ton-That H, Faull KF, Schneewind O, (1999) Multiple enzymatic activities of the murein hydrolase from staphylococcal phage phi11. Identification of a D-alanyl-glycine endopeptidase activity. J Biol Chem 274: 15847-15856.
12. Oliveira H, Melo LD, Santos SB, Nóbrega FL, Ferreira EC, et al. (2013) Molecular aspects and comparative genomics of bacteriophage endolysins. J Virol doi:10.1128/JVI.03277-12.
13. Loeffler JM, Nelson D, Fischetti VA, (2001) Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase. Science 294: 2170-2172.
14. Schuch R, Nelson D, Fischetti VA, (2002) A bacteriolytic agent that detects and kills Bacillus anthracis. Science 418: 884-889.
15. García P, García E, Ronda C, Tomasz A, Lopez R, (1983) Inhibition of lysis by antibody against phage-associated lysin and requirement of choline residues in the cell wall for progeny phage release in Streptococcus pneumoniae. Curr Microbiol 8: 137-140.
16. Obeso JM, Martínez B, Rodríguez A, García P, (2008) Lytic activity of the recombinant staphylococcal bacteriophage PhiH5 endolysin active against Staphylococcus aureus in milk. Int J Food Microbiol 128(2): 212-218.
17. García P, Martínez B, Rodríguez L, Rodríguez A, (2010) Synergy between the phage endolysin LysH5 and nisin to kill Staphylococcus aureus in pasteurized milk. Int J Food Microbiol 141(3): 151-155.
18. Rodríguez L, Martínez B, Zhou Y, Rodríguez A, Donovan DM, et al. (2011) Lytic activity of the virion-associated peptidoglycan hydrolase HydH5 of Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88. BMC Microbiol 11: 138.
19. Rodríguez-Rubio L, Martínez B, Rodríguez A, Donovan DM, García P, (2012) Enhanced staphylolytic activity of the Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88 HydH5 virion-associated peptidoglycan hydrolase: fusions, deletions, and synergy with LysH5. Appl Environ Microbiol 78(7): 2241-2248.
20. Becker SC, Dong S, Baker JR, Foster-Frey J, Pritchard DG, et al. (2009) LysK CHAP endopeptidase domain is required for lysis of live staphylococcal cells. FEMS Microbiol Lett 294(1): 52-60.
21. Donovan DM, Foster-Frey J, Dong S, Rousseau GM, Moineau S, et al. (2006) The cell lysis activity of the Streptococcus agalactiae bacteriophage B30 endolysin relies on the cysteine, histidine-dependent amidohydrolase/peptidase domain. Appl Environ Microbiol 72(7): 5108-5112.
22. Horgan M, O'Flynn G, Garry J, Cooney J, Coffey A, et al. (2009) Phage lysin LysK can be truncated to its CHAP domain and retain lytic activity against live antibiotic-resistant staphylococci. Appl Environ Microbiol 75(3): 872-874.
23. Schmelcher M, Korobova O, Schischkova N, Kiseleva N, Kopylov P, et al. (2012) Staphylococcus haemolyticus prophage ΦSH2 endolysin relies on cysteine, histidine-dependent amidohydrolases/peptidases activity for lysis 'from without'. J Biotechnol 162(2-3): 289-298.
24. Donovan DM, Becker SC, Don S, Baker JR, Foster-Frey JA, et al. (2009) Peptidoglycan hydrolase enzyme fusions for treating multi-drug resistant pathogens. Biotech Int 21: 6-10.
25. Fischetti VA, (2008) Bacteriophage lysins as effective antibacterials. Curr Opin Microbiol 11: 393-400.
26. Fischetti VA, (2005) Bacteriophage lytic enzymes: novel anti-infectives. Trends Microbiol 13(10): 491-496.
27. Mo KF, Li X, Li H, Low LY, Quinn CP, et al. (2012) Endolysins of Bacillus anthracis bacteriophages recognize unique carbohydrate epitopes of vegetative cell wall polysaccharides with high affinity and selectivity. J Am Chem Soc 134(37): 15556-15562.
28. García E, García JL, García P, Arrarás A, Sánchez-Puelles JM, et al. (1988) Molecular evolution of lytic enzymes of Streptococcus pneumoniae and its bacteriophages. Proc Natl Acad Sci U S A 85(3): 914-918.
29. Kusuma C, Jadanova A, Chanturiya T, Kokai-Kun JF, (2007) Lysostaphin-resistant variants of Staphylococcus aureus demonstrate reduced fitness in vitro and in vivo. Antimicrob Agents Chemother 51(2): 475-482.